Back to top
more

Inari Medical (NARI)

(Delayed Data from NSDQ)

$43.34 USD

43.34
2,171,856

-2.04 (-4.50%)

Updated Aug 23, 2024 04:00 PM ET

After-Market: $43.40 +0.06 (0.14%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NARI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Inari Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 116 326 176 164 24
Receivables 70 59 42 28 11
Notes Receivable 0 0 0 0 0
Inventories 43 33 21 11 4
Other Current Assets 6 5 6 3 0
Total Current Assets 236 423 245 206 39
Net Property & Equipment 21 22 16 8 3
Investments & Advances 4 9 5 1 1
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 365 0 0 0 0
Deposits & Other Assets 0 0 0 0 0
Total Assets 674 504 312 214 45
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 11 8 7 3 3
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 15 8 11 3 1
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 49 39 24 8 5
Total Current Liabilities 76 56 43 14 9
Mortgages 0 0 0 0 0
Deferred Taxes/Income 36 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 19
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 66 0 1 0 1
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 209 87 72 14 30
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 54
Common Stock (Par) 0 0 0 0 0
Capital Surplus 504 463 257 228 2
Retained Earnings -48 -47 -18 -27 -41
Other Equity 9 1 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 465 417 239 200 15
Total Liabilities & Shareholder's Equity 674 504 312 214 45
Total Common Equity 465 417 239 200 -39
Shares Outstanding 57.50 53.60 50.20 48.70 NA
Book Value Per Share 8.09 7.78 4.77 4.11 0.00

Fiscal Year End for Inari Medical, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 110 102 116 351 338
Receivables 82 79 70 70 63
Notes Receivable 0 0 0 0 0
Inventories 49 45 43 40 39
Other Current Assets 9 8 6 8 5
Total Current Assets 249 233 236 469 445
Net Property & Equipment 23 21 21 21 21
Investments & Advances 4 5 4 9 9
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 348 355 365 0 0
Deposits & Other Assets 0 0 0 0 0
Total Assets 673 662 674 549 525
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 0 0 0
Accounts Payable 16 12 11 10 7
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 66 34 15 13 11
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 54 39 49 41 38
Total Current Liabilities 138 86 76 66 58
Mortgages 0 0 0 0 0
Deferred Taxes/Income 35 35 36 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 45 66 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 249 215 209 97 89
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 529 518 504 497 484
Retained Earnings -104 -73 -48 -44 -47
Other Equity -1 2 9 -1 -1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 424 447 465 452 436
Total Liabilities & Shareholder's Equity 673 662 674 549 525
Total Common Equity 424 447 465 452 436
Shares Outstanding 58.20 58.10 57.50 57.50 57.30
Book Value Per Share 7.28 7.70 8.09 7.86 7.60